![](https://investorshub.advfn.com/uicon/108458.png?cb=1482855649)
Sunday, May 26, 2024 11:06:34 AM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent ATHA News
- Athira to Host Webinar Highlighting Potential for Fosgonimeton to Protect and Preserve Neuronal Health in Mild-to-Moderate Alzheimer’s Disease Patients • GlobeNewswire Inc. • 06/12/2024 11:00:00 AM
- Athira Pharma Completes First Cohort in Phase 1 Clinical Trial of ATH-1105, an Oral, Small Molecule Drug Candidate for Amyotrophic Lateral Sclerosis (ALS) • GlobeNewswire Inc. • 06/11/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2024 08:05:10 PM
- Athira Pharma to Participate in Upcoming June Conferences • GlobeNewswire Inc. • 05/29/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 11:03:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 10:58:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 10:56:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 09:00:13 PM
- Athira Pharma Announces Proposed Settlement of Stockholder Derivative Action • GlobeNewswire Inc. • 05/17/2024 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:10:16 PM
- Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates • GlobeNewswire Inc. • 05/15/2024 08:05:00 PM
- Athira Pharma to Participate in Upcoming May Conferences • GlobeNewswire Inc. • 05/02/2024 11:00:00 AM
- Athira Pharma Appoints Javier San Martin, M.D., as Chief Medical Officer • GlobeNewswire Inc. • 04/15/2024 11:00:00 AM
- Athira Pharma Announces Publication of Preclinical Data Highlighting Fosgonimeton Treatment in Models of Alzheimer’s Disease • GlobeNewswire Inc. • 04/11/2024 11:00:00 AM
- Athira Pharma Announces Upcoming Poster Presentation at American Academy of Neurology (AAN) 2024 Annual Meeting • GlobeNewswire Inc. • 04/03/2024 11:00:00 AM
- Athira Pharma Presents Clinical and Preclinical Data Supporting Therapeutic Potential of Fosgonimeton in Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International Conference • GlobeNewswire Inc. • 03/08/2024 12:00:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/22/2024 09:34:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/22/2024 09:10:13 PM
- Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates • GlobeNewswire Inc. • 02/22/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 10:01:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:54:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/16/2024 09:46:40 PM
- Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] • Edgar (US Regulatory) • 02/16/2024 09:40:35 PM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM